The Impact of Ketoanalogues on Nephropathy Progression in Advanced Chronic Kidney Disease Older Patients
Advanced chronic kidney disease (CKD) can be treated with conservative care or renal replacement therapies. CKD is associated with an increased risk of nephropathy progression, and death. Therefore, slow down CKD progression is crucial, and there is consensus regarding protein intake regulation bene...
- Autores:
-
Aroca-Martinez, Gustavo
Sierra, Angélica
Barros-Camargo, Luis
Pertuz-Pinzon, Adolfo
Dianda, Daniela
Cadena-Bonfanti, Andrés
Musso, Carlos G.
- Tipo de recurso:
- Fecha de publicación:
- 2022
- Institución:
- Universidad Simón Bolívar
- Repositorio:
- Repositorio Digital USB
- Idioma:
- eng
- OAI Identifier:
- oai:bonga.unisimon.edu.co:20.500.12442/11632
- Acceso en línea:
- https://hdl.handle.net/20.500.12442/11632
https://www.actascientific.com/ASNH/pdf/ASNH-06-1156.pdf
- Palabra clave:
- Chronic Kidney Disease
Ketoanalogues
Progression
- Rights
- openAccess
- License
- Attribution-NonCommercial-NoDerivatives 4.0 Internacional
| Summary: | Advanced chronic kidney disease (CKD) can be treated with conservative care or renal replacement therapies. CKD is associated with an increased risk of nephropathy progression, and death. Therefore, slow down CKD progression is crucial, and there is consensus regarding protein intake regulation benefit in delaying this progression. Ketoanalogues are nitrogen-free analogs of essential amino acids which supplements low protein diets. Thus, it was decided to evaluate if keto diet had benefit in reducing CKD progression |
|---|